Liminatus Pharma, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $4.26-$154.50 |
Market Cap | $5.9M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$24 |
News
See moreYahoo Finance • 10 days ago
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
Yahoo Finance • 16 days ago
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
Yahoo Finance • 10 months ago
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Yahoo Finance • last year
Form 8K Liminatus Pharma Inc For: 25 August
About
CEO | Mr. Chris Kim J.D., L.L.M. |
Address | 12611 Hiddencreek Way, Cerritos, CA, United States, 90703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |